TelmisartanThird Party Manufacturing in India

Telmisartan works by selectively blocking the binding of angiotensin II to the angiotensin II type 1 (AT1) receptor.

Angiotensin II is a potent vasoconstrictor that also stimulates aldosterone secretion. By insurmountably antagonizing this receptor, Telmisartan causes blood vessels to relax and inhibits aldosterone production, which reduces sodium and water retention and effectively lowers blood pressure.

Unlike many other ARBs, Telmisartan also acts as a partial agonist of the PPAR-γ receptor, which is involved in regulating glucose and lipid metabolism. This dual mechanism gives Telmisartan unique metabolic benefits. It is highly effective and well-tolerated for patients with hypertension and those requiring cardiovascular risk reduction.

Therapeutic Uses

Telmisartan is prescribed for the treatment of:

• Hypertension: Effectively lowers elevated blood pressure, either alone or in combination with other antihypertensive agents.
• Cardiovascular Risk Reduction: Reduces the risk of myocardial infarction, stroke, or death from cardiovascular causes in high-risk patients.
• Diabetic Nephropathy: Offers protective effects on kidney function in patients with type 2 diabetes and hypertension.

Why Manufacturers Choose Telmisartan

Telmisartan boasts the longest half-life among ARBs, providing sustained 24-hour blood pressure control with a single daily dose. Its unique dual mechanism and lack of dry cough (a common side effect of ACE inhibitors) make it a highly desirable and premium antihypertensive choice.

This makes Telmisartan one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.